INVA vs UNH: fair value comparison
Innoviva, Inc. and UnitedHealth Group Incorporated · Updated 2026-09-06
INVA currently screens as fairly valued while UNH screens as undervalued. Within Healthcare, UNH currently sits closer to the top of our discount ranking. INVA carries the stronger quality grade.
| INVA | UNH | |
|---|---|---|
| Verdict | Fairly valued | Undervalued |
| Last price | $20.77 | $397.14 |
| 12-month range | $18.11–$23.41 | $273.98–$415.36 |
| Sector rank | #60 of 113 Healthcare | #55 of 113 Healthcare |
| Quality grade | B | F |
| Leverage | Low | Moderate |
| Margin trend | — | Contracting |
| Revenue growth | — | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | — |
| DCF cross-check | — | Undervalued |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: INVA fair value analysis · UNH fair value analysis